Nova Financial’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
Other funds holding UNCY
Nova Financial's UNCY Position: Q3 2026 in Review
Nova Financial opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 910 shares worth $4.27K. The stake represents ﹤0.01% of the portfolio and ranks #676 among its holdings.
91 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.
- Nova Financial held 910 shares of Unicycive Therapeutics worth $4.27K as of Q3 2026.
- Unicycive Therapeutics was a new Nova Financial position in Q3 2026.
- Unicycive Therapeutics made up ﹤0.01% of Nova Financial's portfolio in Q3 2026, its #676 holding.
- 91 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.
Based on Nova Financial's 13F filing for Q3 2026, filed 4 Nov 2026.